Evaluating Arrhythmia Risk in Patients with Chronic Obstructive Pulmonary Disease Treated with Aclidinium/Formoterol Fumarate and Other Inhaled Bronchodilators: A Post-Authorization Safety Study.

Saved in:
Bibliographic Details
Title: Evaluating Arrhythmia Risk in Patients with Chronic Obstructive Pulmonary Disease Treated with Aclidinium/Formoterol Fumarate and Other Inhaled Bronchodilators: A Post-Authorization Safety Study.
Authors: Rebordosa C; RTI Health Solutions, Barcelona, Spain., Aguado J; RTI Health Solutions, Barcelona, Spain., Bartsch J; RTI Health Solutions, Research Triangle Park, NC, USA., Saigi-Morgui N; RTI Health Solutions, Barcelona, Spain., Carsin AE; RTI Health Solutions, Barcelona, Spain., Garcia-Esteban R; RTI Health Solutions, Barcelona, Spain., Ignatova E; Covis Pharma Gmbh, a Wholly-Owned Subsidiary of Azurity Pharmaceuticals, Inc., Woburn, MA, USA., Freedman D; Covis Pharma Gmbh, a Wholly-Owned Subsidiary of Azurity Pharmaceuticals, Inc., Woburn, MA, USA., Perez-Gutthann S; RTI Health Solutions, Barcelona, Spain., Rivero-Ferrer E; RTI Health Solutions, Barcelona, Spain.
Source: International journal of chronic obstructive pulmonary disease [Int J Chron Obstruct Pulmon Dis] 2026 Jan 16; Vol. 21, pp. 554888. Date of Electronic Publication: 2026 Jan 16 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: DOVE Medical Press Country of Publication: New Zealand NLM ID: 101273481 Publication Model: eCollection Cited Medium: Internet ISSN: 1178-2005 (Electronic) Linking ISSN: 11769106 NLM ISO Abbreviation: Int J Chron Obstruct Pulmon Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1178-2005
DOI:10.2147/COPD.S554888